Concepedia

Three Distinct d-Amino Acid Substitutions Confer Potent Antiangiogenic Activity on an Inactive Peptide Derived from a Thrombospondin-1 Type 1 Repeat

David W. Dawson, Olga V. Volpert, S. Frieda A. Pearce, Andrew J. Schneider, Roy L. Silverstein, Jack Henkin, Noël Bouck

Molecular Pharmacology · 1999 · 144 citations · 27 references

DOI

Concepts

References

27

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

Thomas Boehm, Judah Folkman, Timothy Browder et al. · Nature · 1997 · 1.7K citations

, , +16

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

Deborah J. Good, Peter J. Polverini, Farzan Rastinejad et al. · Proceedings of the National Academy of Sciences · 1990 · 1.1K citations · Full text

, , +13

CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells

David W. Dawson, S. Frieda A. Pearce, Ruiqin Zhong et al. · The Journal of Cell Biology · 1997 · 678 citations · Full text

, , +10

Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.

Paul Börnstein · The Journal of Cell Biology · 1995 · 668 citations · Full text

, , +9

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

SS Tolsma, DJ Good, W. D. Frazier et al. · The Journal of Cell Biology · 1993 · 573 citations · Full text

, , +15